Insulin Resistance and Polycystic Ovarian Syndrome

1. EVALUATION FOR INSULIN RESISTANCE AND CO-MORBIDITIES RELATED TO INSULIN RESISTANCE IN PCOS Ricardo Azziz, MD, MPH, MBA Dept. of Ob/Gyn, Cedars-Sinai Medical Center, and Depts. of Ob/Gyn and Medicine, The David Geffen School of Medicine at UCLA, Los Angeles, CA, USA 2. FAT DISTRIBUTION AND ADIPOSE PRODUCTS IN PCOS Running title: Adipose products in PCOS Enrico Carmina, M.D. Department of Clinical Medicine, University of Palermo, Palermo, Italy 3. Treatment of Infertility in PCOS: Ovulation Induction Running head: Ovulation Induction in PCOS Authors: Deborah S. Wachs, MD University of California, San Diego School of Medicine Department of Reproduction Medicine *R. Jeffery Chang, MD University of California, San Diego School of Medicine Department of Reproduction Medicine 4. IMAGING STUDIES IN POLYCYSTIC OVARY SYNDROME Sophie JONARD, MD 1, Yann ROBERT, MD 2, Yves ARDAENS, MD 2 and Didier DEWAILLY, MD 1 1 Department of Endocrine Gynaecology and Reproductive Medecine, Hopital Jeanne de Flandre, Centre Hospitalier et Universitaire de Lille, France 2 Department of Radiology, Hopital Jeanne de Flandre, Centre Hospitalier et Universitaire de Lille, France 5. GENES RELATED TO METABOLIC ABNORMALITIES OR INSULIN RESISTANCE IN PCOS SHORT TITLE: Insulin resistance genes in PCOS Hector F. Escobar-Morreale, MD, PhD Department of Endocrinology, Hospital Ramon y Cajal & Department of Medicine, Universidad de Alcala, Madrid, Spain 6. ANTI-ANDROGENS Kur_ad Unluhizarci, M.D. and Fahrettin Kele_timur, M.D. Department of Endocrinology, Erciyes University Medical School, Kayseri, Turkey 7. LIPID ABNORMALITIES IN PCOS Abbreviated title: Lipids and PCOS Djuro Macut, M.D., PhD. Institute of Endocrinology, Diabetes and Diseases of Metabolism, Dr Subotica 13, 11000 Belgrade, Serbia 8. Serine Phosphorylation, Insulin Resistance, and the Regulation OF ANDROGEN SYNTHESIS Running title: Serine phosphorylation, insulin resistance, and steroidogenesis Andrew A. Bremer M.D., Ph.D.*, Walter L. Miller, M.D. Department of Pediatrics, University of California, San Francisco *Supported by Pediatric Endocrinology Training Grant T32 DK07161 9. CHRONIC TREATMENT OF POLYCYSTIC OVARIAN SYNDROME: ORAL CONTRACEPTIVE PILLS Running Title: PCOS and OCP treatment Shahla Nader, M.D. Departments of Obstetrics, Gynecology & Reproductive Sciences and Internal Medicine The University of Texas Medical School - Houston 10. INSULIN SENSITIZING DRUGS FOR THE TREATMENT OF INFERTILITY IN POLYCYSTIC OVARY SYNDROME (Insulin Sensitizing Drugs in PCOS) Cynthia S. Ryan, MDa, John E. Nestler, MDbc aClinical Fellow, Division of Endocrinology and Metabolism, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia bWilliam G. Blackard Professor of Medicine and Chair, Division of Endocrinology and Metabolism, Medical College of Virginia, Virginia Commonwealth University; and cVice Chair Department of Internal Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 11. DIET AND LIFESTYLE FACTORS IN THE AETIOLOGY AND MANAGEMENT OF POLYCYSTIC OVARY SYNDROME R. J. NORMAN1 and L.J. MORAN2 1Research Centre for Reproductive Health and Repromed, The Queen Elizabeth Hospital University of Adelaide South Australia, Australia 2CSIRO Human Nutrition, Kintore Avenue, Adelaide 5000 South Australia, Australia 12. ADRENARCHE: THE INTERRELATIONSHIP OF ANDROGENS/ INSULIN ON THE DEVELOPMENT OF THE METABOLIC SYNDROME/ PCOS Running Head: Adrenarche: Metabolic Syndrome/ PCOS Authors: Sharon E. Oberfield, M.D(1), Natasha Leibel, M.D. (1), Lauren Antler B.A. (1), Miriam Silfen, M.D. (1), Lenore S. Levine, M.D. (1), Mary Horlick, M.D. (1), Goldy Carbunaru M.D.(2), Ximena Lopez, M.D.(2) and Songya Pang M.D. (2) Institution: (1) Morgan Stanley's Children's Hospital of New York-Presbyterian (NY, NY) (2) University of Illinois Hospital, Department of Pediatrics (Chicago, IL) 13. Cardiovascular disease and inflammation Running head : PCOS and CVD Francesco Orio1, Evanthia Diamanti-Kandarakis2, Stefano Palomba3 1 Department of Molecular and Clinical Endocrinology & Oncology, University "Federico II", Naples, Italy 2 Endocrine Section of First Department of Internal Medicine, Athens University School of Medicine, Athens, Greece 3 Department of Obstetrics and Gynecology, University "Magna Graecia", Catanzaro, Italy 14. Surgery and laser diathermy Stefano Palomba*, Fulvio Zullo*, Evanthia Diamanti-Kandarakis^, Francesco Orio JrA *Department of Obstetrics & Gynecology, University "Magna Graecia" of Catanzaro A Department of Endocrinology and Molecular Oncology, University "Federico II" of Naples, Italy ^Endocrine Section, First Department of Medicine, University of Athens, Greece 15. Late pregnancy complications in polycystic ovarian syndrome Short running title: Late pregnancy complications in PCOS Dimitrios Panidis1, Neoklis A. Georgopoulos2 1 Professor of Endocrinology Division of Endocrinology and Human Reproduction, Second Department of Obstetrics and Gynaecology, Aristotle University of Thessaloniki, Thessaloniki, Greece 2 Lecturer of Reproductive Endocrinology Department of Obstetrics and Gynaecology, Division of Reproductive Endocrinology, Patras Medical School, Patras, Greece 16. Glucose intolerance Running head: Glucose intolerance Vincenzo Toscano Dipartimento di Fisiopatologia Medica - University of Rome La Sapienza II FacoltA di Medicina e Chirurgia 17. HORMONAL AND BIOCHEMICAL EVALUATION OF POLYCYSTIC OVARY SYNDROME Bulent O. Yildiz, M.D. Hacettepe University Faculty of Medicine, Department of Internal Medicine, Endocrinology and Metabolism Unit, Ankara, Turkey, 06100 18. ENDOMETRIAL CARCINOMA IN PCOS Emmanuel Diakomanolis Alexandra Hospital, Athens Greece 19. STATINS, OXIDATIVE STRESS, AND PCOS Pinar H. Kodaman and Antoni J. Duleba Yale University School of Medicine Department of Obstetrics/Gynecology New Haven, CT O6520 20. GLUCOSE INTOLERANCE IN PCOS: FOCUS ON THE ss-CELL Running Title: Diabetes in PCOS David A. Ehrmann, M.D. Department of Medicine, University of Chicago, Chicago, IL. 21. PCOS: definitions and epidemiology Bart C.J.M. Fauser1 Frank J. Broekmans1 Joop S.E. Laven2 Nick S. Macklon1 Basil Tarlatzis3 1 Department of Reproductive Medicine & Gynecology, University Medical Center, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands E mail; b.c.fauser@umcutrecht.nl 2 Center of Reproductive Medicine Erasmus Medical Center, Rotterdam, The Netherlands 3 Unit for Human Reproduction, 1st Department of Obstetrics & Gynecology, Aristotle University of Thessaliniki, Greece 22. ANOVULATION IN POLYCYSTIC OVARY SYNDROME Stephen Franks Institute of Reproductive and Developmental Biology, Wolfson and Weston Research Centre for Family Health, Imperial College London, Hammersmith Hospital, London, W12 0NN, UK 23. NON-ALCOHOL_C FATTY L_VER D_SEASE _N PCOS Walter Futterweit, M.D., F.A.C.P. * Clinical Professor of Medicine, Division of Endocrinology, Mount Sinai School of Medicine, New York, N.Y., 10029 24. "SECONDARY" POLYCYSTIC OVARY SYNDROME Gregory Kaltsas1 & George Chrousos2 The Department of Pathophysiology1 & the First Department of Paediatrics2, Athens University Medical School, Athens, Greece 25. LONG TERM SEQUELAE OF POLYCYSTIC OVARY SYNDROME: ASSOCIATION WITH INSULIN RESISTANCE AND THE METABOLIC SYNDROME Richard S. Legro, M.D., Professor, Department of Obstetrics and Gynecology, Pennsylvania State University College of Medicine, Hershey, PA 26. THE INSULIN RESISTANCE OF POLYCYSTIC OVARY SYNDROME Short title: The insulin resistance of PCOS Merik Demissie Ph.D.1, Richard S. Legro, M.D. 2, Andrea Dunaif, M.D. 1 1 The Division of Endocrinology and Molecular Medicine, The Feinberg School of Medicine, Northwestern University, Chicago, USA 2 The Department of Obstetrics and Gynecology, Pennsylvania State University, Hershey, PA, USA 27. THERAPEUTIC ASPECTS OF POLYCYSTIC OVARY SYNDROME IN ADOLESCENCE George MASTORAKOS, Carolina KOLIOPOULOS, George CREATSAS Endocrine Unit, 2nd Department of Obstetrics and Gynecology, ARETAIEION Hospital, Medical School of CAPODISTRIAKON Athens University 28. Lifestyle intervention in PCOS Running head: Lifestyle intervention in PCOS Onno E. Janssen, M.D., Susanne Tan, M.D. and Susanne Hahn, M.D. Div. of Endocrinology, Dept. of Medicine, University Hospital of Essen Medical School, Hufelandstrasse 55, 45122 Essen, Germany 29. INVOLVEMENT OF THE ENDOCANNABINOID SYSTEM IN METABOLISM AND FERTILITY: POTENTIAL IMPLICATION IN THE POLYCYSTIC OVARY SYNDROME Uberto Pagotto, Alessandra Gambineri, Valentina Vicennati, and Renato Pasquali Endocrinology Unit, Department of Internal Medicine and Gastroenterology and C.R.B.A., S.Orsola-Malpighi Hospital, Alma Mater Studiorum University of Bologna, 40138 Bologna, Italy. 30. Insulin resistance: definition and epidemiology in normal women and PCOS women. Renato Pasquali and Alessandra Gambineri Endocrinology Unit, Dept. of Internal Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Italy. 31. Clinical evaluation of Polycystic Ovary Syndrome Ann E. Taylor, MD Pfizer Global Research and Development, Groton, CT 06340, United States 32. PHARMACEUTICAL INTERVENTION IN METABOLIC AND CARDIOVASCULAR RISK FACTORS IN PCOS Evanthia Diamanti-Kandarakis, MD Associate Professor, Medical School, University of Athens, Greece 33. INSULIN RESISTANCE AND EARLY PREGNANCY LOSS IN POLYCYSTIC OVARY SYNDROME Daniela Jakubowicz1, MD and Susmeeta T. Sharma2, MBBS 1 Division of Reproductive Endocrinology. Department of Medicine Hospital de Clinicas Caracas, Venezuela. 2 Division of Endocrinology & Metabolism, Virginia Commonwealth University, Richmond, Virginia, USA.